Rein Therapeutics, Inc. Common Stock (RNTX)

Typically moves ±7.63% on earnings
EARNINGS ANALYTICS
search

Rein Therapeutics, Inc. Common Stock (RNTX) has reported earnings 4 times since May 15, 2024. The stock moves an average of ±7.63% the day after reporting, closing higher 0.0% of the time. Its largest post-earnings gain was -1.29% (May 15, 2024) and its largest decline was -16.14% (Nov 14, 2024).

Earnings reactions

How RNTX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

4

Avg Abs. Movement

±7.63%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 15, 2025 ☽ POST -1.73% open_in_new
Nov 14, 2024 ☽ POST -16.14% open_in_new
Aug 14, 2024 ☽ POST -11.35% open_in_new
May 15, 2024 ☽ POST -1.29% open_in_new
event

Earnings Count

4

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.63%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 8 →
8
Funds holding
$1061695
Total value held
Buying
7 added · 0 reduced
State Street Corp
$394788 +400.11%
Blackrock, Inc.
$339253 +376.02%
Northern Trust Corp
$166109 +149.03%
Goldman Sachs Group Inc
$82976 NEW BUY
Ubs Group Ag
$59706 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
8-K 20260904 open_in_new SEC.gov
8-K 20260827 open_in_new SEC.gov
10-Q 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260813 open_in_new SEC.gov
8-K 20260721 open_in_new SEC.gov
SCHEDULE 13G/A 20260714 open_in_new SEC.gov
ARS 20260608 open_in_new SEC.gov
DEF 14A 20260608 open_in_new SEC.gov

Frequently asked about RNTX earnings

How much does RNTX stock move after earnings? expand_more

Over 4 reports, RNTX has moved an average of ±7.63% the session after earnings, closing higher 0.0% of the time.

What was RNTX's biggest post-earnings move? expand_more

RNTX's largest post-earnings gain on record was -1.29% on May 15, 2024, and its largest decline was -16.14% on Nov 14, 2024.

Where can I find Rein Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Rein Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers